There is a potential for significant differences in quantitative results for certain specimens when using the affected reagent lots.
Source facts
Action
Abbott affiliates in Canada, Germany, Australia, New Zealand, England and Japan were e-mailed copies of the recall letter on 8/27/04 for translation where needed and dissemination to their accounts receiving the suspect lots. The end users were advised of the potential for significant differences in quantitative results for certain specimens and were instructed to discontinue use and destroy any of the affected lots remaining.
Initiated
2004-08-27
Root cause
Other
Terminated
2005-07-29
Distribution
Canada, Japan, Australia, New Zealand, Germany and England
Recall number
Z-1498-04
Recall status
Terminated
CDRH record ID
34786
FDA classified
2004-09-30
Recall event number
29922
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.